Adam L. Perlman
Latham & Watkins LLPGeneral
Experience20 yrs
Elite Ratings
DCT
Practice Areas
Chemical Biotech (15 cases)
Biotech (127 cases)
Chemical (10 cases)
Comp. Arch. and Software (2 cases)
Communications (1 case)
Ratings
Experience
Grade
Trend
DCT
L4
A
PTAB
--
--
--
CAFC
L5
A
Cases
Case # | Court | Caption | Filed | Represent |
|---|---|---|---|---|
| 1:23-CV-01277 | Eli Lilly Co v. MSN Laboratories Pvt Ltd | 11/08/23 | Patent Owner | |
| 1:23-CV-00732 | Biogen Inc. v. Zydus Worldwide DMCC | 07/06/23 | Patent Owner | |
| 1:23-CV-00031 | Amgen Inc v. MSN Laboratories Pvt Ltd | 01/12/23 | Patent Owner | |
| 1:22-CV-01115 | Eli Lilly Co v. MSN Laboratories Pvt Ltd | 08/24/22 | Patent Owner | |
| 1:22-CV-01114 | Eli Lilly Co v. Aurobindo Pharma Ltd | 08/24/22 | Patent Owner | |
| 1:22-CV-00387 | KAI Pharma Inc v. USV Pvt Ltd | 03/25/22 | Patent Owner | |
| 1:22-CV-00379 | Merck Sharp & Dohme Corp v. Zenara Pharma Pvt Ltd | 03/23/22 | Patent Owner | |
| 1:22-CV-00378 | PF Prism Imb BV v. Hetero USA Inc | 03/23/22 | Patent Owner | |
| 1:22-CV-00377 | Merck Sharp & Dohme Corp v. Aurobindo Pharma Ltd | 03/23/22 | Patent Owner | |
| 1:22-CV-00227 | KAI Pharma Inc v. AuroMedics Pharma LLC | 02/22/22 | Patent Owner |